Switching of monoclonal antibodies against the calcitonin gene-related peptide or its receptor in migraine. Results from a Spanish Cohort
Background: Switching between calcitonin gene-related peptide (CGRP) and monoclonal antibodies (mAbs) may be a beneficial strategy after discontinuation. The aim of this study was to evaluate switching outcomes of effectiveness/tolerability. Methods: Retrospective multicentric study of migraine pati...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Elsevier
    
        2024-10-01 | 
| Series: | Neurology Perspectives | 
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667049624000255 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       